US FDA Grants QRX003 Rare Pediatric Disease Designation for Peeling Skin Syndrome

The US Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) Designation for Quoin Pharmaceuticals Ltd’s QRX003 for the treatment of Peeling Skin Syndrome (PSS).